Gastroesophageal reflux disease and asthma

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 1, 2010, Pages 60-63

  Parsons, Jonathan P ^a   Mastronarde, John G ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Asthma; Gastroesophageal reflux disease; Treatment

Indexed keywords

CORTICOSTEROID; ESOMEPRAZOLE; HISTAMINE H1 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ASTHMA; CLINICAL TRIAL; CONSENSUS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE TITRATION; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG FUNCTION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATHOGENESIS; PH; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; REVIEW;

ANTI-ASTHMATIC AGENTS; ASTHMA; GASTROESOPHAGEAL REFLUX; HUMANS; PREVALENCE; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 74549201252     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328332ca2f     Document Type: Review

References (28)

1. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999; 115:654-659.
2. Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990; 99:613-620.
3. Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000; 162:34-39.
4. National Heart Lung and Blood Institute Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart Lung and Blood Institute; 2007. Report No. 07-4051.
5. Behavioral risk factor surveillance system survey data (database on the Internet). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009 [Accessed 24 June 2009].
6. Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112:1448-1456.
7. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135:1383-1391.
8. Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360:1487-1499.
9. Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997; 111:1389-1402.
10. Ekstrom T, Tibbling L. Esophageal acid perfusion, airway function, and symptoms in asthmatic patients with marked bronchial hyperreactivity. Chest 1989; 96:995-998.
11. Wu DN, Tanifuji Y, Kobayashi H, et al. Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bronchial asthma. Chest 2000; 118:1553-1556.
12. Jack CI, Calverley PM, Donnelly RJ, et al. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50:201-204.
13. Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984; 87:872-881.
14. Choy D, Leung R. Gastro-oesophageal reflux disease and asthma. Respirology 1997; 2:163-168.
15. Zerbib F, Guisset O, Lamouliatte H, et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med 2002; 166:1206-1211.
16. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100:395-405.
17. Ford GA, Oliver PS, Prior JS, et al. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebocontrolled cross-over study. Postgrad Med J 1994; 70:350-354.
18. Teichtahl H, Kronborg IJ, Yeomans ND, Robinson P. Adult asthma and gastrooesophageal reflux: the effects of omeprazole therapy on asthma. Aust N Z J Med 1996; 26:671-676.
19. Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A doubleblind, placebo-controlled crossover study. Dig Dis Sci 1994; 39:2127-2133.
20. Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998; 93:1060-1063.
21. Boeree MJ, Peters FT, Postma DS, Kleibeuker JH. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J 1998; 11:1070-1074.
22. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest 1999; 116:1257-1264.
23. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2000: CD001496.
24. Littner MR, Leung FW, Ballard ED 2nd, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005; 128:1128-1135.
25. Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006; 173:1091-1097.
26. Tomonaga T, Awad ZT, Filipi CJ, et al. Symptom predictability of refluxinduced respiratory disease. Dig Dis Sci 2002; 47:9-14.
27. Dimango E, Holbrook JT, Simpson E, et al. Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity. Am J Respir Crit Care Med 2009; 180:809-816.
28. Asano K, Suzuki H. Silent acid reflux and asthma control. N Engl J Med 2009; 360:1551-1553.